The Haemophilus influenzae type b (Hib) vaccine protects children from severe bacterial infections caused by the type b strain of Haemophilus influenzae. The vaccine goes by different brand names depending on the manufacturer and formulation.
The Hib vaccine is available under several brand names, including:
These vaccines contain the polysaccharide capsule of the Hib bacteria attached to a carrier protein, which helps stimulate a stronger immune response in young children.
The Hib vaccine works by introducing a small piece of the bacteria (its polysaccharide capsule) to the immune system. This triggers the production of antibodies that can recognize and fight off actual Hib infections. The carrier protein helps improve the immune response in infants, who often don't respond well to pure polysaccharide vaccines.
The Centers for Disease Control and Prevention (CDC) recommends routine vaccination for all children starting at 2 months old. The standard schedule includes doses at 2, 4, 6, and 12-15 months. Children with certain immune deficiencies or asplenia may need additional doses.
One common misconception is that the Hib vaccine protects against all types of Haemophilus influenzae. In reality, it only targets the type b strain, which was historically responsible for most serious infections in children. Other strains exist but don't cause the same severe diseases.
Another misunderstanding is that the vaccine causes the disease. This is impossible because the vaccine contains only inactive components of the bacteria, not live organisms.
When I worked in public health, I encountered parents concerned about multiple vaccines at once. The Hib vaccine is often combined with others (like DTaP or hepatitis B) to reduce the number of injections children receive. These combination vaccines have the same safety profile as individual ones.